McKesson Corporation  

(Public, NYSE:MCK)   Watch this stock  
Find more results for MCK
-1.16 (-0.71%)
May 26 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 161.12 - 162.90
52 week 114.53 - 199.43
Open 162.04
Vol / Avg. 1.13M/2.01M
Mkt cap 33.75B
P/E 6.75
Div/yield 0.28/0.69
EPS 23.89
Shares 210.90M
Beta 1.11
Inst. own 89%
Jul 27, 2017
McKesson Corp Annual Shareholders Meeting (Estimated) - 8:30AM EDT - Add to calendar
Jul 25, 2017
Q1 2018 McKesson Corp Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
May 18, 2017
Q4 2017 McKesson Corp Earnings Call - Webcast
May 18, 2017
Q4 2017 McKesson Corp Earnings Release
Mar 2, 2017
McKesson Corp Financial Update on Change Healthcare Transaction Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '17) 2017
Net profit margin 7.45% 2.66%
Operating margin 9.70% 3.58%
EBITD margin - 2.13%
Return on average assets 24.50% 8.98%
Return on average equity 153.51% 51.89%
Employees 78,000 -
CDP Score - D


1 Post St
SAN FRANCISCO, CA 94104-5203
United States - Map
+1-415-9838300 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia


McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, which is a payment technology.

Officers and directors

John Harvey Hammergren Chairman of the Board, President, Chief Executive Officer
Age: 58
Bio & Compensation  - Reuters
James A. Beer Chief Financial Officer, Executive Vice President
Age: 56
Bio & Compensation  - Reuters
Kathleen D. McElligott Executive Vice President, Chief Technology Officer, Chief Information Officer
Age: 61
Bio & Compensation  - Reuters
Lori Ann Schechter Executive Vice President, Chief Compliance Officer, General Counsel
Age: 55
Bio & Compensation  - Reuters
Jorge L. Figueredo Executive Vice President - Human Resources
Age: 56
Bio & Compensation  - Reuters
Paul Coleman Julian Executive Vice President, Group President
Age: 61
Bio & Compensation  - Reuters
Bansi Nagji Executive Vice President - Corporate Strategy and Business Development
Age: 52
Bio & Compensation  - Reuters
Edward A. Mueller Lead Independent Director
Age: 69
Bio & Compensation  - Reuters
Andrew D. Bryant Independent Director
Age: 66
Bio & Compensation  - Reuters
Wayne A. Budd Independent Director
Age: 75
Bio & Compensation  - Reuters